Replicative senescence and cell immortality: The role of telomeres and telomerase

Proceedings of the Society for Experimental Biology and Medicine

Volumn 214, Issue 2, 1997, Pages 99-106

  Chiu, Choy Pik ^a   Harley, Calvin B ^a  

^a GERON CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL CELL; CELL AGING; CELL DIVISION; CELL IMMORTALIZATION; CHROMOSOME STRUCTURE; GENETIC STABILITY; HUMAN; HUMAN CELL; MITOSIS; MOLECULAR DYNAMICS; NONHUMAN; SENESCENCE; SHORT SURVEY; TELOMERE;

EID: 0031047426     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-214-44075     Document Type: Short Survey

References (81)

1. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621, 1961.
2. Cristofalo VJ, Pignolo RJ. Replicative senescence of human fibroblast-like cells in culture. Physiol Rev 73:617-638, 1993.
3. Linskens MHK, Feng J, Andrews WH, Enlow BE, Saati SM, Tonkin LA, Funk WD, Villeponteau B. Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res 23:3244-3251, 1995.
4. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano E, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363-9367, 1995.
5. Wistrom C, Villeponteau B. Cloning and expression of SAG: A novel marker of cellular senescence. Exp Cell Res 199:355-362, 1992.
6. West MD, Pereira-Smith OM, Smith JR. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp Cell Res 184:138-147, 1989.
7. Linskens MH, Harley CB, West MD, Campisi J, Hayflick L. Replicative senescence and cell death. (letter) Science 267:17, 1995.
8. Stanulis-Praeger BM. Cellular senescence revisited: A review. Mech Ageing Dev 38:1-48, 1987.
9. Goldstein S. Aging in vitro: Growth of cultured cells from the Galapagos tortoise. Exp Cell Res 89:297-302, 1974.
10. Rohme D. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci USA 78:5009-5013, 1981.
11. Martin GM. Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects Orig Artic Ser 14:5-39, 1978.
12. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52:661-667, 1993.
13. Harley CB. Telomeres and Aging. In: Telomeres. New York: Cold Spring Harbor Laboratory Press, pp247-263, 1995.
14. + T cells in centenarians and in long-term T cell cultures: A possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 29:601-609, 1994.
15. West MD. The cellular and molecular biology of skin aging. Arch Dermatol 130:87-95, 1994.
16. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196:33-39, 1991.
17. Graham FL, Smiley J. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74, 1977.
18. Hastie ND, Allshire RC. Human telomeres: Fusion, resolution and interstitial sites. Trends Genet Sci 5:326-331, 1989.
19. Zakian VA. Structure and function of telomeres. Annu Rev Genet 23:579-604, 1989.
20. Moyzis R. The human telomere. Sci Am 265:48-55, 1991.
21. Henderson S, Allsopp R, Spector D, Wang S-S, Harley C. In situ analysis of changes in telomere size during replicative aging and cell transformation. J Cell Biol 134:1-12, 1996.
22. Allshire RC, Dempster M, Hastie ND. Human telomeres contain at least three types of G-rich repeats distributed non-randomly. Nucleic Acid Res 17:4611-4627, 1989.
23. de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM, Varmus HE. Structure and variability of human chromosome ends. Mol Cell Biol 10:518-527, 1990.
24. Harley C, Futcher A, Greider C. Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460, 1990.
25. Greider C, Blackburn E. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331-337, 1989.
26. Grieder C, Blackburn E. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 43:405-413, 1985.
27. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59:521-529, 1989.
28. Shippen-Lentz D, Blackburn EH. Functional evidence for an RNA template in telomerase. Science 247:546-552, 1990.
29. Lin JJ, Zakian VA. An in vitro assay for Saccharomyces telomerase requires EST1. Cell 81:1127-1135, 1995.
30. Cohn M, Blackburn EH. Telomerase in yeast. Science 269:396-400, 1995.
31. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
32. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179, 1996.
33. Olovnikov A. A theory of marginotomy: The incomplete copying of template margin in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 41:181-190, 1973.
34. Watson J. Origin of Concatemeric T7 DNA. Nat New Biol 239:197-201, 1972.
35. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CH. Telomere end-replication problem and cell aging. J Mol Biol 225:951-960, 1992.
36. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol 27:375-382, 1992.
37. Harley C. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256:271-282, 1991.
38. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868, 1990.
39. Lindsey J, McGill N, Lindsey L, Green D, Cooke H. In vivo loss of telomeric repeats with age in humans. Mutat Res 256:45-48, 1991.
40. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89:10114-10118, 1992.
41. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860, 1994.
42. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW, Harley CB. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220:194-220, 1995.
43. Chang E, Harley C. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92:11190-11194, 1996.
44. Chen Q, Fischer A, Reagan JD, Van L-J, Ames BN. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 92:4337-4341, 1995.
45. von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hypoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 220:186-193, 1995.
46. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68:3410-3414, 1994.
47. Adamson DJA, King DJ, Haites NE. Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 61:204-206, 1992.
48. Counter C, Avilion A, LeFeuvre C, Stewart N, Greider C, Harley C, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1929, 1992.
49. Schwartz HS, Juliao SF, Sciadini MF, Miller LK, Butler MG. Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer 75:1094-1099, 1995.
50. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 54:3557-3560, 1994.
51. Odagiri E, Kanada N, Jibiki K, Demura R, Aikawa E, Demura H. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer 73:2978-2984, 1994.
52. Van Der Haegen BA, Shay JW. Immortalization of human mammary epithelial cells by SV40 large T-antigen involved a two step mechanism. In Vitro Cell Devel Biol 29A:180-182, 1993.
53. Numberg P, Thiel G, Weber F, Epplen JT. Changes of telomere lengths in human intracranial tumours. Hum Genet 91:190-192, 1993.
54. Sciadini MF, Schwartz HS, Miller LK, Butler MG. Is telomere reduction a generalized phenomenon in chromosomes of solid tissue neoplasms? Proc Annu Meet Am Soc Clin Oncol 13:A314, 1994.
55. Mumane JP, Sabatier L, Marder BA, Morgan WF. Telomere dynamics in an immortal human cell line. EMBO J 13:4953-4962, 1994.
56. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14:4240-4248, 1995.
57. INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 15:4745-4753, 1995.
58. Blackburn EH. Telomeres: Structure and synthesis. J Biol Chem 265:5919-5921, 1990.
59. Newbold RF, Cuthbert AP, Themis M, Trott DA, Blair AL, Li W. Cell immortalization as a key, rate-limiting event in malignant transformation: Approaches toward a molecular genetic analysis. Toxicol Lett 67:211-230, 1993.
60. Chiu C-P, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB, Lansdorp P. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14:239-248, 1996.
61. Shay JW, Wright WE, Werbin H. Loss of telomeric DNA during aging may predispose cells to cancer. (review) Int J Oncol 3:559-563, 1993.
62. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91:2900-2904, 1994.
63. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315-2320, 1995.
64. Broccoli D, Young JW, deLange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92:9082-9086, 1995.
65. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. Immunol 155:3711-3715, 1995.
66. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1:249-255, 1996.
67. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y. Telomerase activity in gastric cancer. Cancer Res 55:3258-3262, 1995.
68. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, Ide T. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55:2734-2736, 1995.
69. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene 13:161-166, 1996.
70. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, Wright WE, Shay JW. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp Quant Biol 59:307-315, 1994.
71. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55:2533-2536, 1995.
72. Singer MS, Gottschling DE. TLCl: Template RNA component of Saccharomyces cerevisiae telomerase. Science 266:404-409, 1994.
73. Yu G-L, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated telomerase RNAs. Nature 344:126-132, 1990.
74. McEachem MJ, Blackburn EH. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376:403-409, 1995.
75. Blasco MA, Funk W, Villeponteau B, Greider CW. Functional characterization and developmental regulation of mouse telomerase RNA. Science 269:1267-1270, 1995.
76. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B. The RNA component of human telomerase. Science 269:1236-1241, 1995.
77. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 92:4818-822, 1995.
78. Chadeneau C, Siegel P, Harley CB, Muller WJ, Bacchetti S. Telomerase activity in normal and malignant murine tissues. Oncogene 11:893-898, 1995.
79. Moore MAS. Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it? Blood 80:3-7, 1992.
80. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 106:759-765, 1996.
81. Hiyama E, Hiyama K, Tatsumoto N, Shay JW, Yokoyama T. Telomerase activity in human intestine. Internat J Oncol 9:453-458, 1996.